Home › Trial NCT02981108
A Study to Evaluate Safety, PK and Efficacy of HS-10296 in Patients With NSCLC
- Trial IDNCT02981108
- StatusUnknown
- PhasePhase 1/2
- Study typeInterventional
- SponsorJiangsu Hansoh Pharmaceutical Co., Ltd.
- Enrollment364
- Start date2017-05-08
- ConditionsNonsmall Cell Lung Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.